Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sanofi's Oral Aubagio Jostles For Position In Multiple Sclerosis Market

This article was originally published in The Pink Sheet Daily

Executive Summary

FDA accepts filing for teriflunomide, but concerns about pregnancy risk in a young patient population and questions about comparative efficacy could limit market potential.
Advertisement

Related Content

Discount Price May Position Aubagio For Greater Than Expected Uptake In Multiple Sclerosis
Genzyme Prices MS Drug Aubagio At Discount To Established Therapies
Sanofi/Genzyme MS Drug Lemtrada Scores High Against Rebif
Sanofi Sets Sights On Multiple Sclerosis Leadership
Sanofi/Genzyme MS Drug Lemtrada Scores High Against Rebif
Merck KGaA Signs Cancer-MS Barter Deal With Japan's Ono
Disappointing BRAVO Data Raise Doubts About Laquinimod's Chances With FDA
Germany's Merck Scraps MS Drug Cladribine After Regulators' Rebuff
Side Effects Dampen Neurologists' Enthusiasm For Novel MS Drugs
Side Effects Dampen Neurologists' Enthusiasm For Novel MS Drugs

Topics

Advertisement
UsernamePublicRestriction

Register

PS072923

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel